CervoMed's three largest insider shareholders as of September 09, 2026 are Sylvie Gregoire (Director, 1.50Mn shares), John J Alam (Ceo President, 1.50Mn shares), Joshua S Boger (Director, 840.45K shares).
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Sylvie Gregoire | Director, TenPercentOwner | 1,484,078 | 12,500 | 1,496,578 | 38.8% | 19 Nov, 2025 |
| 2 | John J Alam | Ceo President | 1,484,078 | 12,500 | 1,496,578 | 38.8% | 19 Nov, 2025 |
| 3 | Joshua S Boger | Director, TenPercentOwner | 0 | 840,451 | 840,451 | 21.8% | 28 Feb, 2024 |
| 4 | Matthew Winton | Chief Commercial And Business | 15,000 | 0 | 15,000 | 0.4% | 19 Nov, 2025 |
| 5 | William Robert Elder | Cfo, Gc Secretary | 12,500 | 0 | 12,500 | 0.3% | 19 Nov, 2025 |
| 6 | Diana M Lanchoney | Director | 294 | 0 | 294 | 0.0% | 30 Jun, 2023 |
| 7 | Robert Joseph Jr. Cobuzzi | President Ceo | 0 | 0 | 0 | 0.0% | 03 Feb, 2023 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 08 Jun, 2026 | Sylvie Gregoire | Director, TenPercentOwner | Acquired A | 8,150 | $0.00 | $0 | 8,150 | Direct |
| 08 Jun, 2026 | Jane H Hollingsworth | Director | Acquired A | 8,150 | $0.00 | $0 | 8,150 | Direct |
| 08 Jun, 2026 | Marwan Sabbagh | Director | Acquired A | 8,150 | $0.00 | $0 | 8,150 | Direct |
| 08 Jun, 2026 | Jeffrey V. Poulton | Director | Acquired A | 8,150 | $0.00 | $0 | 8,150 | Direct |
| 08 Jun, 2026 | Frank Zavrl | Director | Acquired A | 8,150 | $0.00 | $0 | 8,150 | Direct |
| 08 Jun, 2026 | David Quigley | Director | Acquired A | 8,150 | $0.00 | $0 | 8,150 | Direct |
| 11 Feb, 2026 | Sylvie Gregoire | Director, TenPercentOwner | Acquired A | 75,000 | $0.00 | $0 | 75,000 | Indirect |
| 11 Feb, 2026 | Matthew Winton | Chief Commercial And Business | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | Kelly Blackburn | Evp, Clinical Development | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | Matthew Winton | Chief Commercial And Business | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | Rosch Mark De | Evp, Ra And Ga And Pgm | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | William Robert Elder | Cfo, Gc Secretary | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | Rosch Mark De | Evp, Ra And Ga And Pgm | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | Rosch Mark De | Evp, Ra And Ga And Pgm | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | William Robert Elder | Cfo, Gc Secretary | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | Matthew Winton | Chief Commercial And Business | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | William Robert Elder | Cfo, Gc Secretary | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | Matthew Winton | Chief Commercial And Business | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | Rosch Mark De | Evp, Ra And Ga And Pgm | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |
| 11 Feb, 2026 | William Robert Elder | Cfo, Gc Secretary | Acquired A | 30,000 | $0.00 | $0 | 30,000 | Direct |